Literature DB >> 23174626

The occurrence of venous thromboembolism in cancer patients following major surgery.

Thierry H Toledano1, Dimple Kondal, Susan R Kahn, Vicky Tagalakis.   

Abstract

BACKGROUND: Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is common in cancer patients and surgery is an important risk factor.
OBJECTIVE: To describe the occurrence of VTE in cancer patients following major surgery and to determine the risk of VTE recurrence.
METHODS: Using the administrative health claims (RAMQ) and hospital discharge (MED-ECHO) databases of the province of Québec, Canada, we constructed a cohort of all individuals with incident VTE between January 1, 1994 and December 31, 2004 diagnosed with cancer and who had major surgery in the 91days prior to the VTE. The timing of VTE after surgery was determined. Recurrent VTE was defined as re-hospitalization with a principal discharge diagnosis of VTE.
RESULTS: Our cohort consisted of 2706 cancer patients with VTE following major surgery. The mean age was 65.9years (Standard Deviation 12.6) and 54% were female. The median duration of surgical hospitalization was 18days (range 1-735days). The median time to VTE following surgery was 15days (range 1-659days), and 34% of VTE events were diagnosed after hospital discharge. The 1-year cumulative rate of recurrence was 6.7% (95% CI 5.7, 7.9) and the 5-year cumulative rate was 12.6% (95% CI 10.7, 14.7). Increasing comorbidity (adjusted hazard ratio (HR) 2.49, 95% CI 1.58-3.95) and VTE diagnosed after hospital discharge (adjusted HR 1.48, 95% CI 1.09-2.01) were associated with recurrence.
CONCLUSIONS: A significant proportion of VTE episodes among surgical patients with cancer are diagnosed after discharge from hospital. This suggests that surgical patients with cancer are at risk for VTE beyond the immediate postoperative period.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23174626     DOI: 10.1016/j.thromres.2012.10.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review.

Authors:  Christine Klimowicz White; Jessica Langholtz; Zackory T Burns; Susan Kruse; Kimberly Sallee; David H Henry
Journal:  Support Care Cancer       Date:  2014-09-27       Impact factor: 3.603

2.  Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism.

Authors:  Ambarina S Faiz; Imran Khan; Michele G Beckman; Paula Bockenstedt; John A Heit; Roshni Kulkarni; Marilyn Manco-Johnson; Stephan Moll; Thomas L Ortel; Claire S Philipp
Journal:  Thromb Res       Date:  2015-07-05       Impact factor: 3.944

3.  Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.

Authors:  Christine Baumgartner; Alan S Go; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Marc S Williams; Steven H Yale; Jeffrey J VanWormer; Margaret C Fang
Journal:  Thromb Res       Date:  2020-03-05       Impact factor: 3.944

4.  Risk Factors for Venous Thromboembolism following Thoracolumbar Surgery: Analysis of 43,777 Patients from the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2012.

Authors:  Arjun S Sebastian; Bradford L Currier; Sanjeev Kakar; Emily C Nguyen; Amy E Wagie; Elizabeth S Habermann; Ahmad Nassr
Journal:  Global Spine J       Date:  2016-02-17

5.  Golden berry 4β-hydroxywithanolide E prevents tumor necrosis factor α-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells.

Authors:  Kan-Yen Hsieh; Ju-Ying Tsai; Ya-Han Lin; Fang-Rong Chang; Hui-Chun Wang; Chin-Chung Wu
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

6.  Impact of Perioperative Thromboembolic Complications on Future Long-term Risk of Venous Thromboembolism among Medicare Beneficiaries Undergoing Complex Gastrointestinal Surgery.

Authors:  Alessandro Paro; Djhenne Dalmacy; J Madison Hyer; Diamantis I Tsilimigras; Adrian Diaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2021-07-19       Impact factor: 3.452

7.  Efficacy and Safety of Enoxaparin for Preventing Venous Thromboembolic Events following Urologic Laparoscopic Surgery.

Authors:  Takeo Nomura; Mika Takahashi; Kazunori Iwasaki; Tomoya Oribe; Mayuka Shinohara; Yuko Fukuda; Shinsuke Mizoguchi; Fuminori Sato; Hiromitsu Mimata
Journal:  ISRN Urol       Date:  2013-06-02

8.  Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England.

Authors:  A J Walker; J West; T R Card; D J Humes; M J Grainge
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.